Physician

Adam Michael Shuster, DO

According to 2025 Medicare claims, Adam Shuster, DO (NPI: 1417167784) practices pain management in the Cape Coral-Fort Myers, FL market, with the plurality of this provider's patient population coming from Lee, FL. This provider's primary affiliated billing organization is FLORIDA PAIN AND REHABILITATION ASSOCIATES INC (NPI: 1053363457; TIN: 020599723) and primary practice location at 33907-1816. Shuster is affiliated with the Sunflower ACO LLC (ACO ID: A5499) and Primary Care Alliance, LLC (ACO ID: D0010), participating under both the MSSP and REACH models.

Shuster's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 554 traditional Medicare patients, billed 6,462 HCPCS/CPT codes, and received $380,520 in Medicare payments. The top billing code was 62323 (Injection of substance into lower spine canal using imaging guidance). Part D data shows 8,541 prescription claims across 1,321 beneficiaries totaling $457,324 in drug costs, led by Oxycodone-Acetaminophen (Oxycodone Hcl/Acetaminophen). Open Payments data shows 66 records totaling $1,909. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have fallen sharply in recent years, from $933,835 to $457,324. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,584	7,744	$391,961
2016	1,307	8,143	$349,308
2017	1,102	7,219	$329,640
2018	999	6,094	$294,562
2019	927	12,960	$511,188
2020	903	13,284	$533,287
2021	916	11,817	$593,444
2022	1,092	12,356	$630,280
2023	811	8,347	$440,368
2024	554	6,462	$380,520

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	1,536	12,212	$933,835
2016	1,331	11,583	$968,726
2017	1,262	11,273	$852,595
2018	1,405	11,070	$876,799
2019	1,408	10,194	$728,350
2020	1,224	9,790	$714,737
2021	1,199	9,051	$618,491
2022	1,580	9,436	$599,302
2023	1,594	8,573	$474,140
2024	1,321	8,541	$457,324

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
62323	Injection of substance into lower spine canal using imaging guidance	174	261	$201
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	202	345	$96
99203	New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more	113	113	$79
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	151	199	$68
80305	Testing for presence of drug, read by direct observation	166	175	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	1,715	49,967	$74,212
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	1,957	56,633	$64,604
Xtampza Er	Oxycodone Myristate	44	1,310	$31,810
Buprenorphine	Buprenorphine	158	4,426	$27,401
Nurtec Odt	Rimegepant Sulfate	11	406	$24,080

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	66	$1,909	Boston Scientific Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Adam Michael Shuster, DO?

Tedicare shows public-source Medicare data for Adam Michael Shuster, DO (NPI 1417167784), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adam Michael Shuster, DO have ACO affiliation data?

Adam Michael Shuster, DO is shown with ACO affiliation data for Sunflower ACO LLC (MSSP, ACO ID A5499) and Primary Care Alliance, LLC (REACH, ACO ID D0010).

What billing organization is linked to Adam Michael Shuster, DO?

Adam Michael Shuster, DO is linked to FLORIDA PAIN AND REHABILITATION ASSOCIATES INC (billing NPI 1053363457) in the available physician profile data.

Does Adam Michael Shuster, DO have Open Payments data?

Adam Michael Shuster, DO has 66 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.